Xalol (Ksalol) is part of a group of drugs called benzodiazepines (benzo dye-AZE-eh-peens). According to the specialists of this site https://pillintrip.com/medicine/ksalol ksalol affects chemicals in the brain that can become unbalanced and cause anxiety.

Xalolol is used to treat anxiety disorders, panic disorders, and anxiety caused by depression.

Xalol may also be used for other purposes not listed in this guide.


Anxiety disorders.

Xalol tablets (Ksalol) are indicated for the treatment of anxiety disorder (the condition most closely corresponding to the diagnosis of generalized anxiety disorder in the APA Diagnostic and Statistical Manual [DSM-IIIR]) or for the short-term relief of anxiety symptoms. Anxiety or tension associated with the stresses of daily life usually do not require treatment with anxiolytics.

Generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry (anxious anticipation) about two or more life circumstances for 6 months or longer, during which the person has worried about these worries more days than not. These patients often present with at least 6 of the following 18 symptoms: Motor tension (trembling, twitching, or jerking sensation; muscle tension, pain, or soreness; restlessness; mild fatigue); Autonomic hyperactivity (shortness of breath or sensation of choking; palpitations or palpitations; sweating or cold clammy hands; dry mouth; dizziness or delirium; nausea, diarrhea or other abdominal disturbances; hot flashes or chills; frequent urination; swallowing problems or “lump in the throat”);Vigilance and scanning (feeling agitated or on edge; exaggerated fright reactions; difficulty concentrating or “blanking out” due to anxiety; trouble falling asleep or sleeping; irritability). These symptoms should not be secondary to another mental disorder or caused by any organic factor.

Anxiety associated with depression is amenable to Xalol.

Panic disorder.

Xalol is also indicated for the treatment of panic disorder with or without agoraphobia.

Studies supporting this claim have been conducted with patients whose diagnoses closely match the DSM-III-R / IV criteria for panic disorder.

Panic disorder (DSM-IV) is characterized by recurrent, unexpected panic attacks, that is, a discrete period of intense fear or discomfort in which four (or more) of the following symptoms develop abruptly and peak within 10 minutes: (1) palpitations. (2) palpitations or palpitations; (2) sweating; (3) trembling or shaking; (4) feeling of shortness of breath or choking; (5) feeling of suffocation; (6) pain or discomfort in the chest; (7) nausea or abdominal distress; (8) feelings of dizziness, unsteadiness, vertigo, or fainting; (9) derealization (feeling unreal) or depersonalization (separation from self); (10) fear of losing control; (11) fear of death; (12) paresthesias (numbness or tingling); (13) chills or hot flashes.

Demonstration of the efficacy of xalol through systematic clinical trials is limited to a duration of 4 months for anxiety disorder and 4-10 weeks for panic disorder; however, patients with panic disorder have received open-label treatment for up to 8 months without apparent loss of benefit. The physician should periodically reevaluate the usefulness of the drug for the individual patient.